167 related articles for article (PubMed ID: 7506025)
1. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
[TBL] [Abstract][Full Text] [Related]
4. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines.
Dearing MP; Englee-Miller MJ; Kratzke RA; Kramer BS; Chu E; Weinstein J; Anderson M; Venzon D; Mulshine JL; Gazdar AF
J Cell Biochem Suppl; 1996; 24():165-72. PubMed ID: 8806099
[TBL] [Abstract][Full Text] [Related]
6. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
[TBL] [Abstract][Full Text] [Related]
7. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM; McGuire JJ
Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
[TBL] [Abstract][Full Text] [Related]
8. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
9. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
10. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.
Zhu Z; Xu X; Yu Y; Graham M; Prince ME; Carey TE; Sun D
Mol Pharm; 2010 Aug; 7(4):1283-90. PubMed ID: 20540527
[TBL] [Abstract][Full Text] [Related]
11. Variable pharmacodynamics of antifolates in squamous cell carcinoma of the head and neck.
Braakhuis BJ; Jansen G; Peters GJ
Adv Exp Med Biol; 1993; 338():671-4. PubMed ID: 8304205
[No Abstract] [Full Text] [Related]
12. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
Li WW; Lin JT; Schweitzer BI; Bertino JR
Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
[TBL] [Abstract][Full Text] [Related]
15. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
[TBL] [Abstract][Full Text] [Related]
16. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
17. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines.
Klaassen I; Brakenhoff RH; Smeets SJ; Snow GB; Braakhuis BJ
Int J Cancer; 2001 Jun; 92(5):661-5. PubMed ID: 11340568
[TBL] [Abstract][Full Text] [Related]
18. Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductase.
Abraham A; McGuire JJ; Galivan J; Nimec Z; Kisliuk RL; Gaumont Y; Nair MG
J Med Chem; 1991 Jan; 34(1):222-7. PubMed ID: 1992121
[TBL] [Abstract][Full Text] [Related]
19. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
Pizzorno G; Chang YM; McGuire JJ; Bertino JR
Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines.
Hoffmann TK; Leenen K; Hafner D; Balz V; Gerharz CD; Grund A; Balló H; Hauser U; Bier H
Anticancer Drugs; 2002 Jan; 13(1):93-100. PubMed ID: 11914646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
